Finance
Vaccine maker reports 2004 pro forma earnings down more than 50% from 2003
Published in Medical Letter on the CDC and FDA, February 27th, 2005
On a generally accepted accounting principles (GAAP) basis, Chiron reported income from continuing operations of $60 million, or $0.32 per share, for the year ended December 31, 2004, compared to income from continuing operations of $220 million, or $1.15 per share, for the year ended December 31, 2003. Foreign exchange rates resulted in an approximate $0.07 decrease in pro forma earnings per share (EPS) and an approximate $0.08 decrease in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Allergy Medicine
Extraction buffers evaluated using allergenic food protein detection - Anti-Infectives
Human health impact from antimicrobial use in food animals reviewed - Bioterrorism
Advances in responding to bioterrorism and emerging diseases outlined - Endocrinology
New findings in the area of endocrinology described - Meningitis Vaccine
Serogroup A meningococcal vaccines evaluated in Africa - Tuberculosis Vaccine
Mycobacterial heparin-binding hemagglutinin protects against TB - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
